AEGON Asset Management (UK)’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $19M | Sell |
46,759
-85
| -0.2% | -$34.5K | 0.24% | 95 |
|
2025
Q1 | $23.3M | Sell |
46,844
-2,621
| -5% | -$1.3M | 0.34% | 76 |
|
2024
Q4 | $25.7M | Sell |
49,465
-7,919
| -14% | -$4.12M | 0.34% | 73 |
|
2024
Q3 | $35.5M | Buy |
57,384
+507
| +0.9% | +$313K | 0.48% | 51 |
|
2024
Q2 | $31.4M | Buy |
56,877
+50,775
| +832% | +$28M | 0.44% | 57 |
|
2024
Q1 | $3.54M | Sell |
6,102
-602
| -9% | -$350K | 0.05% | 108 |
|
2023
Q4 | $3.56M | Buy |
+6,704
| New | +$3.56M | 0.06% | 106 |
|
2023
Q2 | $3.72M | Sell |
7,129
-662
| -8% | -$345K | 0.06% | 113 |
|
2023
Q1 | $4.49M | Hold |
7,791
| – | – | 0.08% | 110 |
|
2022
Q4 | $4.29M | Buy |
7,791
+1,669
| +27% | +$919K | 0.08% | 111 |
|
2022
Q3 | $3.11M | Sell |
6,122
-380
| -6% | -$193K | 0.06% | 110 |
|
2022
Q2 | $3.54M | Buy |
6,502
+534
| +9% | +$290K | 0.07% | 112 |
|
2022
Q1 | $3.53M | Sell |
5,968
-1,466
| -20% | -$867K | 0.05% | 119 |
|
2021
Q4 | $4.96M | Buy |
7,434
+165
| +2% | +$110K | 0.06% | 126 |
|
2021
Q3 | $4.15M | Sell |
7,269
-922
| -11% | -$527K | 0.06% | 126 |
|
2021
Q2 | $4.13M | Hold |
8,191
| – | – | 0.06% | 129 |
|
2021
Q1 | $3.74M | Sell |
8,191
-343
| -4% | -$157K | 0.06% | 125 |
|
2020
Q4 | $3.97M | Hold |
8,534
| – | – | 0.06% | 116 |
|
2020
Q3 | $3.76M | Buy |
8,534
+584
| +7% | +$258K | 0.08% | 96 |
|
2020
Q2 | $2.88M | Buy |
7,950
+1,177
| +17% | +$426K | 0.06% | 102 |
|
2020
Q1 | $1.92M | Hold |
6,773
| – | – | 0.06% | 114 |
|
2019
Q4 | $2.2M | Buy |
6,773
+2,656
| +65% | +$862K | 0.05% | 129 |
|
2019
Q3 | $1.2M | Hold |
4,117
| – | – | 0.03% | 152 |
|
2019
Q2 | $1.21M | Hold |
4,117
| – | – | 0.03% | 156 |
|
2019
Q1 | $1.13M | Buy |
+4,117
| New | +$1.13M | 0.03% | 151 |
|
2017
Q1 | – | Sell |
-4,107
| Closed | -$580K | – | 250 |
|
2016
Q4 | $580K | Sell |
4,107
-217
| -5% | -$30.6K | 0.02% | 207 |
|
2016
Q3 | $688K | Buy |
+4,324
| New | +$688K | 0.02% | 191 |
|